PMVP Q1 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-0.41

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$315M

Total Liabilities

$23M

Stockholders' Equity

$292M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$19M	-$12M	-59.5%
Net Income	-$18M	-$12M	-58.9%